Loading...
Chemical structure of Canverixin

GC68618

Canverixin

Also listed as ACT-1004-1239

ACT-1004-1239 is an effective, selective, orally available CXCR7 antagonist with an IC50 value of 3·2 nM

ChemicalCAS2178049-58-4MW522.55FormulaC27H28F2N6O3
CAS number
2178049-58-4
Molecular weight
522.55
Formula
C27H28F2N6O3
Solubility
DMSO ： 20 mg/mL (38·27 mM; Need ultrasonic)
InChIKey
IIDSHAJKXPUYSL-FPOVZHCZSA-N
Catalogue number
GC68618
Brand
GLPBIO
Computed properties PubChem CID 139360137 · XLogP 2.8 · TPSA 113 Ų · H-bond donors 2
XLogP
2.8
TPSA
113 Ų
H-bond donors
2
H-bond acceptors
9
Rotatable bonds
8
Heavy atoms
38

SMILES C1CN(C[C@@H]([C@H]1NC(=O)C2=NOC(=C2)C3=C(C=C(C=C3)F)F)C(=O)NC4(CC4)C5=NC=CC=N5)CC6CC6

Computed descriptors from PubChem (CID 139360137), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.